ClinConnect ClinConnect Logo
Search / Trial NCT06373198

Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina.

Launched by HOSPITAL EL CRUCE · Apr 17, 2024

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Viral Hepatitis Treatment Direct Antivirals Agents Relink Linkage To Care

ClinConnect Summary

This clinical trial is focused on helping people in Argentina who have been diagnosed with chronic Hepatitis C (HCV) but are not currently receiving treatment. Hepatitis C is a serious infection that can lead to severe health problems, and many patients are unaware of its urgency, often because they feel fine and do not see the need for treatment. The trial aims to reconnect these patients with healthcare services and encourage them to start treatment, which has improved significantly in recent years.

To participate in this trial, individuals need to be over 18 years old and have a diagnosis of chronic Hepatitis C. This study is not yet recruiting participants, but once it begins, eligible individuals can expect to receive support and information to help them understand their condition and the importance of treatment. The ultimate goal is to make it easier for people to access the care they need, which is a crucial step toward eliminating Hepatitis C as a public health concern in Argentina.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All of the following inclusion criteria must be met.
  • Over 18 years old
  • Diagnosis of chronic HCV
  • Exclusion Criteria:
  • no

About Hospital El Cruce

Hospital El Cruce is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Buenos Aires, Argentina, the hospital is renowned for its multidisciplinary approach, combining cutting-edge technology with a commitment to evidence-based practices. As a clinical trial sponsor, Hospital El Cruce prioritizes patient safety and ethical standards while fostering collaboration with researchers and healthcare professionals. The institution aims to contribute valuable insights to the medical community by exploring new therapies and treatment modalities across various fields, ultimately enhancing the quality of care for diverse patient populations.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported